AAAAAA
Results: 76-100/103
Authors:
JENG MH
JIANG SY
JORDAN VC
Citation: Mh. Jeng et al., PARADOXICAL REGULATION OF ESTROGEN-DEPENDENT GROWTH-FACTOR GENE-EXPRESSION IN ESTROGEN-RECEPTOR (ER)-NEGATIVE HUMAN BREAST-CANCER CELLS STABLY EXPRESSING ER, Cancer letters, 82(2), 1994, pp. 123-128
Authors:
JORDAN VC
Citation: Vc. Jordan, SPECIAL ISSUE - ANTIESTROGENS - APPLICATIONS AND ACTIONS, Breast cancer research and treatment, 31(1), 1994, pp. 1-3
Authors:
DRAGAN YP
FAHEY S
STREET K
VAUGHAN J
JORDAN VC
PITOT HC
Citation: Yp. Dragan et al., STUDIES OF TAMOXIFEN AS A PROMOTER OF HEPATOCARCINOGENESIS IN FEMALE FISCHER F344 RATS, Breast cancer research and treatment, 31(1), 1994, pp. 11-25
Authors:
FRIEDL A
JORDAN VC
Citation: A. Friedl et Vc. Jordan, WHAT DO WE KNOW AND WHAT DONT WE KNOW ABOUT TAMOXIFEN IN THE HUMAN UTERUS, Breast cancer research and treatment, 31(1), 1994, pp. 27-39
Authors:
JORDAN VC
Citation: Vc. Jordan, MOLECULAR MECHANISMS OF ANTIESTROGEN ACTION IN BREAST-CANCER, Breast cancer research and treatment, 31(1), 1994, pp. 41-52
Authors:
WOLF DM
JORDAN VC
Citation: Dm. Wolf et Vc. Jordan, CHARACTERIZATION OF TAMOXIFEN STIMULATED MCF-7 TUMOR VARIANTS GROWN IN ATHYMIC MICE, Breast cancer research and treatment, 31(1), 1994, pp. 117-127
Authors:
WOLF DM
JORDAN VC
Citation: Dm. Wolf et Vc. Jordan, THE ESTROGEN-RECEPTOR FROM A TAMOXIFEN STIMULATED MCF-7 TUMOR VARIANTCONTAINS A POINT MUTATION IN THE LIGAND-BINDING DOMAIN, Breast cancer research and treatment, 31(1), 1994, pp. 129-138
Authors:
SARKARIA JN
MILLER EM
PARKER CJ
JORDAN VC
MULCAHY RT
Citation: Jn. Sarkaria et al., 4-HYDROXYTAMOXIFEN, AN ACTIVE METABOLITE OF TAMOXIFEN, DOES NOT ALTERTHE RADIATION SENSITIVITY OF MCF-7 BREAST-CARCINOMA CELLS IRRADIATED IN-VITRO, Breast cancer research and treatment, 30(2), 1994, pp. 159-165
Authors:
GARCIAMORALES P
SACEDA M
KENNEY N
KIM N
SALOMON DS
GOTTARDIS MM
SOLOMON HB
SHOLLER PF
JORDAN VC
MARTIN MB
Citation: P. Garciamorales et al., EFFECT OF CADMIUM ON ESTROGEN-RECEPTOR LEVELS AND ESTROGEN-INDUCED RESPONSES IN HUMAN BREAST-CANCER CELLS, The Journal of biological chemistry, 269(24), 1994, pp. 16896-16901
Authors:
SARGENT LM
DRAGAN YP
BAHNUB N
WILEY JE
SATTLER CA
SCHROEDER P
SATTLER GL
JORDAN VC
PITOT HC
Citation: Lm. Sargent et al., TAMOXIFEN INDUCES HEPATIC ANEUPLOIDY AND MITOTIC SPINDLE DISRUPTION AFTER A SINGLE IN-VIVO ADMINISTRATION TO FEMALE SPRAGUE-DAWLEY RATS, Cancer research, 54(13), 1994, pp. 3357-3360
Authors:
WOLF DM
LANGANFAHEY SM
PARKER CJ
MCCAGUE R
JORDAN VC
Citation: Dm. Wolf et al., INVESTIGATION OF THE MECHANISM OF TAMOXIFEN-STIMULATED BREAST-TUMOR GROWTH WITH NONISOMERIZABLE ANALOGS OF TAMOXIFEN AND METABOLITES, Journal of the National Cancer Institute, 85(10), 1993, pp. 806-812
Authors:
JORDAN VC
MORROW M
Citation: Vc. Jordan et M. Morrow, AN APPRAISAL OF STRATEGIES TO REDUCE THE INCIDENCE OF BREAST-CANCER, Stem cells, 11(4), 1993, pp. 252-262
Authors:
JORDAN VC
Citation: Vc. Jordan, HOW SAFE IS TAMOXIFEN, BMJ. British medical journal, 307(6916), 1993, pp. 1371-1372
Authors:
SARKARIA JN
LINDSTROM MJ
JORDAN VC
FOWLER JF
MULCAHY RT
Citation: Jn. Sarkaria et al., THE INFLUENCE OF TUMOR PROLIFERATION AND TREATMENT TIME ON GROWTH DELAY IN HUMAN BREAST-TUMOR XENOGRAFTS TREATED WITH FRACTIONATED RADIATION, International journal of radiation oncology, biology, physics, 27, 1993, pp. 142-143
Authors:
JENG MH
TENDIJKE P
IWATA KK
JORDAN VC
Citation: Mh. Jeng et al., REGULATION OF THE LEVELS OF 3 TRANSFORMING GROWTH-FACTOR-BETA MESSENGER-RNAS BY ESTROGEN AND THEIR EFFECTS ON THE PROLIFERATION OF HUMAN BREAST-CANCER CELLS, Molecular and cellular endocrinology, 97(1-2), 1993, pp. 115-123
Authors:
WELSHONS WV
GRADY LH
JUDY BM
JORDAN VC
PREZIOSI DE
Citation: Wv. Welshons et al., SUBCELLULAR COMPARTMENTALIZATION OF MCF-7 ESTROGEN-RECEPTOR SYNTHESISAND DEGRADATION, Molecular and cellular endocrinology, 94(2), 1993, pp. 183-194
Authors:
MORROW M
JORDAN VC
Citation: M. Morrow et Vc. Jordan, RISK-FACTORS AND THE PREVENTION OF BREAST-CANCER WITH TAMOXIFEN, Cancer surveys, 18, 1993, pp. 211-229
Authors:
GIBSON DFC
JOHNSON DA
LANGANFAHEY SM
LABABIDI MK
WOLBERG WH
JORDAN VC
Citation: Dfc. Gibson et al., THE EFFECTS OF INTERMITTENT PROGESTERONE UPON TAMOXIFEN INHIBITION OFTUMOR-GROWTH IN THE 7,2-DIMETHYLBENZANTHRACENE RAT MAMMARY-TUMOR MODEL, Breast cancer research and treatment, 27(3), 1993, pp. 283-287
Authors:
WOLF DM
JORDAN VC
Citation: Dm. Wolf et Vc. Jordan, DRUG-RESISTANCE TO TAMOXIFEN DURING BREAST-CANCER THERAPY, Breast cancer research and treatment, 27(1-2), 1993, pp. 27-40
Authors:
JIANG SY
PARKER CJ
JORDAN VC
Citation: Sy. Jiang et al., A MODEL TO DESCRIBE HOW A POINT MUTATION OF THE ESTROGEN-RECEPTOR ALTERS THE STRUCTURE-FUNCTION RELATIONSHIP OF ANTIESTROGENS, Breast cancer research and treatment, 26(2), 1993, pp. 139-147
Authors:
GIBSON DFC
JOHNSON DA
GOLDSTEIN D
LANGANFAHEY SM
BORDEN EC
JORDAN VC
Citation: Dfc. Gibson et al., HUMAN RECOMBINANT INTERFERON-BETA(SER) AND TAMOXIFEN - GROWTH SUPPRESSIVE EFFECTS FOR THE HUMAN BREAST-CARCINOMA MCF-7 GROWN IN THE ATHYMICMOUSE, Breast cancer research and treatment, 25(2), 1993, pp. 141-150
Authors:
CATHERINO WH
JORDAN VC
Citation: Wh. Catherino et Vc. Jordan, A RISK-BENEFIT ASSESSMENT OF TAMOXIFEN THERAPY, Drug safety, 8(5), 1993, pp. 381-397
Authors:
JENG MH
LANGANFAHEY SM
JORDAN VC
Citation: Mh. Jeng et al., ESTROGENIC ACTIONS OF RU486 IN HORMONE-RESPONSIVE MCF-7 HUMAN BREAST-CANCER CELLS, Endocrinology, 132(6), 1993, pp. 2622-2630
Authors:
SARKARIA JN
GIBSON DFC
JORDAN VC
FOWLER JF
LINDSTROM MJ
MULCAHY RT
Citation: Jn. Sarkaria et al., TAMOXIFEN-INDUCED INCREASE IN THE POTENTIAL DOUBLING TIME OF MCF-7 XENOGRAFTS AS DETERMINED BY BROMODEOXYURIDINE LABELING AND FLOW-CYTOMETRY, Cancer research, 53(18), 1993, pp. 4413-4417
Authors:
JORDAN VC
Citation: Vc. Jordan, GROWTH-FACTOR REGULATION BY TAMOXIFEN IS DEMONSTRATED IN PATIENTS WITH BREAST-CANCER, Cancer, 72(1), 1993, pp. 1-2